文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

男男性行为者未来猴痘暴发情景:基于荷兰2022年横断面血清流行率数据的建模研究

Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022.
PubMed 文献 · Euro Surveill · 2024-01-01

研究结合荷兰鹿特丹和阿姆斯特丹性健康中心1065名男男性行为者的横断面血清流行率数据与随机传播模型,评估未来猴痘暴发风险。VACV特异性抗体血清流行率在鹿特丹为45.4%、阿姆斯特丹为47.1%。模型显示风险人群疫苗接种对原暴发影响可能较小,但在不同情景下未来暴发病例数因疫苗接种而显著减少,当前免疫水平本身可能不足以预防未来暴发,维持短诊断时间是新暴发预防策略的关键组成部分。

要点

  • 鹿特丹和阿姆斯特丹MSM中VACV特异性IgG血清流行率分别为45.4%和47.1%。
  • 模型显示风险人群疫苗接种对原暴发影响可能较小,但未来暴发病例数因接种显著减少。
  • 当前免疫水平本身可能不足以预防未来暴发,维持短诊断时间是关键策略组件。

核心结论

  • 当前条件下荷兰MSM未来大规模猴痘暴发可能性降低,但强调维持人群免疫、诊断能力和疾病意识的重要性。

研究设计与样本

  • 结合荷兰鹿特丹和阿姆斯特丹性健康中心1065名MSM的横断面血清流行率研究与随机传播模型,血清采于荷兰猴痘暴发高峰后及疫苗接种引入后。
  • 对鹿特丹性健康中心就诊的MSM,血清与流行病学和疫苗接种数据关联。
  • 使用内部开发的ELISA检测痘苗病毒(VACV)特异性IgG。
  • 将观察数据与已发表的系列间隔和疫苗有效性数据结合,用于随机传播模型。

主要发现

  • VACV特异性抗体血清流行率在鹿特丹为45.4%,在阿姆斯特丹为47.1%。
  • 传播模型显示风险人群疫苗接种对原始暴发的影响可能较小。
  • 假设不同情景,未来暴发中的猴痘病例数因疫苗接种而显著减少。
  • 当前免疫水平本身可能不足以预防未来暴发。
  • 维持短诊断时间是任何预防新暴发策略的关键组成部分。

临床怎么用

  • 作者认为应维持人群免疫、诊断能力和疾病意识。
  • 作者指出维持短诊断时间是任何预防新暴发策略的关键组成部分。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundFollowing the 2022-2023 mpox outbreak, crucial knowledge gaps exist regarding orthopoxvirus-specific immunity in risk groups and its impact on future outbreaks.AimWe combined cross-sectional seroprevalence studies in two cities in the Netherlands with mathematical modelling to evaluate scenarios of future mpox outbreaks among men who have sex with men (MSM).MethodsSerum samples were obtained from 1,065 MSM attending Centres for Sexual Health (CSH) in Rotterdam or Amsterdam following the peak of the Dutch mpox outbreak and the introduction of vaccination. For MSM visiting the Rotterdam CSH, sera were linked to epidemiological and vaccination data. An in-house developed ELISA was used to detect vaccinia virus (VACV)-specific IgG. These observations were combined with published data on serial interval and vaccine effectiveness to inform a stochastic transmission model that estimates the risk of future mpox outbreaks.ResultsThe seroprevalence of VACV-specific antibodies was 45.4% and 47.1% in Rotterdam and Amsterdam, respectively. Transmission modelling showed that the impact of risk group vaccination on the original outbreak was likely small. However, assuming different scenarios, the number of mpox cases in a future outbreak would be markedly reduced because of vaccination. Simultaneously, the current level of immunity alone may not prevent future outbreaks. Maintaining a short time-to-diagnosis is a key component of any strategy to prevent new outbreaks.ConclusionOur findings indicate a reduced likelihood of large future mpox outbreaks among MSM in the Netherlands under current conditions, but emphasise the importance of maintaining population immunity, diagnostic capacities and disease awareness.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Shamier MC, Zaeck LM, Götz HM, et al. Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022. Euro Surveill. 2024. PMID: 38666400. doi:10.2807/1560-7917.ES.2024.29.17.2300532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。